LAUREN BLEVINS: Open Payments
NPI 1124852736 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,926 in 173 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $352 · 2025 $2,926
Food & beverage: $2,826Education: $100
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $413 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $404 |
| Otsuka America Pharmaceutical, Inc. | 30 | $398 |
| Teva Pharmaceuticals USA, Inc. | 9 | $283 |
| ABBVIE INC. | 21 | $282 |
| Vanda Pharmaceuticals Inc. | 19 | $226 |
| Lundbeck LLC | 9 | $178 |
| Neurocrine BioSciences, Inc. | 8 | $170 |
| Janssen Pharmaceuticals, Inc | 9 | $169 |
| Noven Therapeutics, LLC | 12 | $144 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, INGREZZA, HETLIOZ, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
